Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • PharmaTutor
    24 March 2010

    Deaths during clinical trials on rise as India turning as hot destination

    Even as the dust is yet to settle down over the HPV vaccine trial and death of three tribal girls in Andhra Pradesh, records showed that the total number of deaths among the clinical trial subjects, though not officially termed as part of the trials, are on the increase in India.

  • 24 March 2010
    Syngene, Endo Pharmaceuticals in oncology deal

     Bangalore, Mar, 23, 2010: Syngene International, a subsidiary of Biocon has entered into a discovery and development collaboration with Endo Pharmaceuticals, USA to develop novel biological therapeutic molecules against cancer.

    Under the agreement Endo will retain all rights to the molecules developed, while Syngene International will receive research fees, milestone payments and success fees from Endo.

     [adsense:336x280:8701650588]

  • 23 March 2010
    Drug-resistant tuberculosis now at record levels: WHO report

    In some areas of the world, one in four people with tuberculosis (TB) becomes ill with a form of the disease that can no longer be treated with standard drugs regimens, a World Health Organization (WHO) report says.

  • 23 March 2010
    Recession hit West storms into India for clinical research, pharmacovigilance next growth path for CROs

     India’s clinical research organizations (CROs) are set for exponential growth going by the number of assignments which are coming in here. The global economic slowdown which has seriously impacted western world has benefited the Indian clinical research industry. Scores of assignments are pouring in to conduct clinical trials, pharmacovigilance studies and data management works.

  • 23 March 2010
    FDA Temporarily Suspends Use of Rotarix Vaccine

    March 22, 2010 — The US Food and Drug Administration (FDA) announced today viral contamination of GlaxoSmithKline's Rotarix vaccine. The agency is recommending that doctors stop using the vaccine until further investigations are complete.

    An independent academic research team testing the product recently identified porcine circovirus 1 in the vaccine and notified regulators.

  • 20 March 2010
    High-Dose Simvastatin Associated With Increased Risk for Myopathy

     March 19, 2010 — Simvastatin (Zocor, Merck/Schering-Plough Pharmaceuticals), used at the highest approved dose of 80 mg, is associated with an increased risk for myopathy, including rhabdomyolysis, according to the US Food and Drug Administration (FDA).

  • 20 March 2010
    Local players to continue domination in anti-fungal drug market in India: F&S

     With fast-paced advancements in technology, the number of patients diagnosed with systemic fungal infections (SFIs) is expected to increase steadily over the next five years, says a new analysis from Frost & Sullivan entitled Systemic Fungal Infection Therapeutics Market – India.

  • 20 March 2010
    Drugs of Crores Rs. seized by Tamil nadu drug authorities

    In a series of raids conducted in several places of the city and in various parts of the state during the last 10 days, the state drug authorities have detected several illegal activities of the pharma traders in which expired and label tampered drugs worth lakhs of rupees were seized from shops of stockists and residences of unlicensed persons

  • 20 March 2010
    Intas Pharma to introduce world’s first Interferon Lozenges in tablet form for flu in India

    Following the recent license and supply agreement signed between Amarillo Biosciences Inc. (ABI), a US biotechnology firm, and Intas Pharmaceuticals, Intas will soon market world’s first Interferon Lozenges (tablet form) in India.

  • 19 March 2010
    IPA demands amendment of D&C Act, separate University for pharmacy in TN

     The Indian Pharmaceutical Association (IPA) has demanded to amend the Drugs & Cosmetics Act and Rules 1945 to make only the pharmacy graduates eligible to become expert staffs in the pharma manufacturing units. In the resolutions passed during the just concluded IPA Convention, the IPA also urged the government to expedite action to amend the Rules in such way that all regulatory positions in the country must be an exclusive area for experienced and qualified pharmacists.

    [adsense:336x280:8701650588]

Subscribe to Pharma News